Skip to content
Open access

666. ADHD: genes and risk for other conditions

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i242 - i243 · 0 citations

TL;DR

A biologically integrative model of ADHD is supported in which circadian, immune, and metabolic processes interact with genetic liability across development, indicating a robust gene–environment interaction operating early in development.

Abstract

Abstract Background Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder characterized by substantial clinical heterogeneity and frequent comorbidity with sleep disturbances, inflammatory conditions, and metabolic dysregulation. While ADHD has traditionally been conceptualized as a disorder of cognitive control and reward processing, accumulating evidence suggests that broader biological systems—including circadian regulation, immune signaling, and metabolic pathways—play a critical role in its pathophysiology. However, how genetic liability for ADHD converges with these systems across development remains insufficiently understood. Aims & Objectives This presentation aims to clarify the biological heterogeneity of ADHD by integrating evidence from longitudinal cohort studies and large-scale genetic analyses. Specifically, we seek to identify shared genetic pathways linking ADHD with circadian, inflammatory, and metabolic traits, to examine early-life gene–environment interactions shaping symptom trajectories, and to discuss translational implications for prevention and intervention. Method We synthesize findings from multiple population-based and genetic epidemiological studies, including genome-wide association studies (GWAS) of ADHD and related traits, together with data from a longitudinal birth cohort in Japan. Analytical approaches include polygenic risk score (PRS) analyses, linkage disequilibrium score regression, Mendelian randomization, gene-set enrichment analysis, and structural equation modeling. Key biological domains examined are circadian regulation (melatonin secretion and chronotype), immune and inflammatory processes (perinatal cytokines), and metabolic signaling (adiponectin). ADHD symptoms were assessed longitudinally to capture developmental trajectories. Results Across studies, ADHD showed significant genetic overlap with circadian traits, including reduced melatonin secretion and evening chronotype, with evidence for bidirectional causal relationships. Higher polygenic liability for ADHD predicted delayed sleep onset and longer sleep induction time in children, while genetic liability for evening chronotype was associated with greater ADHD symptom severity. Immune-related mechanisms emerged as a central biological component linking circadian and developmental findings. Gene-set analyses consistently highlighted shared immune and cytokine-related pathways across ADHD and circadian traits. In addition, perinatal inflammation independently increased ADHD symptom severity and significantly amplified the effect of ADHD polygenic risk, indicating a robust gene–environment interaction operating early in development. Finally, in the metabolic domain, lower cord blood adiponectin levels were associated with higher ADHD symptoms and worsening symptom trajectories. Genetic liability for ADHD showed a negative association with adiponectin levels, linking ADHD risk to metabolic regulation and long-term physical health vulnerability. Discussion & Conclusions These findings support a biologically integrative model of ADHD in which circadian, immune, and metabolic processes interact with genetic liability across development. Genetic overlap with circadian traits indicates that altered sleep timing and melatonin regulation are core components of ADHD biology rather than secondary consequences. Immune dysregulation, particularly during the perinatal period, appears to play a key role in amplifying genetic risk and shaping developmental trajectories. Metabolic alterations, reflected by reduced adiponectin levels, further link ADHD genetic liability to later physical health vulnerability. Together, these results underscore the value of biologically informed stratification of ADHD and point toward prevention-oriented strategies targeting sleep regulation, immune balance, and metabolic health alongside core behavioral symptoms.

Read PDF

Similar papers

Open access Sep 2026

428. ADHD: neurocognitive pathways

These findings highlight emotion dysregulation and its associated right pars orbitalis forming a neurocognitive pathway to ADHD, and reveal that the expansion of the hippocampus as a potential target for facilitating symptom remission in ADHD.

Q. Luo · 0 citations
Review Open access Sep 2026

Phenotypic and genetic relations between attention-deficit/hyperactivity disorder and substance use disorders

In this sample, ADHD was associated with increased risk for SUDs and earlier onset of substance use and genetic liability to ADHD was independently associated with multiple SUDs and SUD criteria counts.

Michael R. Setzer, R. Kember, Emily E. Hartwell et al. · 0 citations
Review Open access Sep 2026

A review of attention-deficit/hyperactivity disorder: Causes, diagnosis, treatment, and impact.

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity that impair functioning across the lifespan. This narrative review critically synthesizes current evidence on ADHD etiology, diagnosis, treatment, and managemen...

Oluwanifemi Christiana Bamgboye, Samiat Mojisola Busari, Chidinma Geraldine Muojekwu et al. · 0 citations
Open access Sep 2026

145. Cortical thinning and hippocampal expansion as brain signatures of ADHD symptom trajectories

Abstract Background Attention-deficit/hyperactivity disorder (ADHD) affects around 5% of children and adolescents world-wide and is characterized by its significant clinical heterogeneity, including different symptom courses, such as persistent, remitting, and emergent trajectories during adolescence and adulthood, whi...

W. Hou, B. Sahakian, S. Cortese et al. · 0 citations
Open access Sep 2026

712. Comorbid mental and substance use disorders – the role of genetic susceptibility

It is demonstrated that the relationship between alcohol use and psychiatric disorders is driven by a complex, shared genetic architecture rather than environmental complications alone and underscores the value of multi-ancestry and cross-disorder genetic studies in SUD.

O. Andreassen, R. Icick, E. Wistrom et al. · 0 citations
Review Open access Sep 2026

Neurodevelopmental reward dysregulation and addiction risk in ADHD.

Attention-deficit/hyperactivity disorder (ADHD) is associated with an elevated risk of substance use disorders (SUDs), yet most affected individuals do not develop addiction, indicating that vulnerability is selectively distributed rather than intrinsic to the disorder itself. This Review synthesizes current evidence o...

R. J. Custodio, Eugene C. Yi, Bung-Nyun Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.